glycoprotein exhibited significantly increased survival rates
calcium phosphate particles produce strong adjuvant effects
experimental mucosal adjuvants include cholera toxin
mucosal adjuvant confers protective antiviral immunity
coulter n4plus submicron particle sizer
epstein-barr virus proteins induced high titers
calcium phosphate nanoparticles induce mucosal immunity
end-point dilution enzyme-linked immunosorbent assay
hsv-2+cap showed reduced clinical severity compared
herpes simplex virus type 2
previously
